NO992309D0 - Process for the use of cyclooxygenase-2 inhibitors as anti-angiogenic agents - Google Patents
Process for the use of cyclooxygenase-2 inhibitors as anti-angiogenic agentsInfo
- Publication number
- NO992309D0 NO992309D0 NO992309A NO992309A NO992309D0 NO 992309 D0 NO992309 D0 NO 992309D0 NO 992309 A NO992309 A NO 992309A NO 992309 A NO992309 A NO 992309A NO 992309 D0 NO992309 D0 NO 992309D0
- Authority
- NO
- Norway
- Prior art keywords
- cyclooxygenase
- inhibitors
- angiogenic agents
- angiogenic
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3140496P | 1996-11-19 | 1996-11-19 | |
PCT/US1997/021489 WO1998022101A2 (en) | 1996-11-19 | 1997-11-19 | Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
NO992309D0 true NO992309D0 (en) | 1999-05-12 |
NO992309L NO992309L (en) | 1999-05-12 |
Family
ID=21859277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO992309A NO992309L (en) | 1996-11-19 | 1999-05-12 | Process for the use of cyclooxygenase-2 inhibitors as anti-angiogenic agents |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0941080A2 (en) |
JP (1) | JP2001505564A (en) |
KR (1) | KR20000053362A (en) |
CN (1) | CN1247470A (en) |
AU (1) | AU730211B2 (en) |
BR (1) | BR9713522A (en) |
CA (1) | CA2270469C (en) |
CZ (1) | CZ176899A3 (en) |
ID (1) | ID21979A (en) |
IL (1) | IL129604A (en) |
NO (1) | NO992309L (en) |
NZ (1) | NZ335853A (en) |
PL (2) | PL194717B1 (en) |
RO (1) | RO118566B1 (en) |
RU (1) | RU2268716C2 (en) |
SK (1) | SK59999A3 (en) |
TR (1) | TR199901703T2 (en) |
UA (1) | UA70294C2 (en) |
WO (1) | WO1998022101A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6512121B2 (en) | 1998-09-14 | 2003-01-28 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
US6515014B2 (en) | 1995-06-02 | 2003-02-04 | G. D. Searle & Co. | Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
US6887893B1 (en) | 1997-12-24 | 2005-05-03 | Sankyo Company, Limited | Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia |
US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
US20030013739A1 (en) * | 1998-12-23 | 2003-01-16 | Pharmacia Corporation | Methods of using a combination of cyclooxygenase-2 selective inhibitors and thalidomide for the treatment of neoplasia |
AU2713500A (en) * | 1998-12-23 | 2000-07-31 | G.D. Searle & Co. | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
CA2363590A1 (en) * | 1999-03-10 | 2000-09-14 | G.D. Searle & Co. | Method and composition for administering a cyclooxygenase-2 inhibitor |
PT1206256E (en) * | 1999-07-29 | 2005-09-30 | Amgen Inc | COMBINATION THERAPY USING PENTAFLUOROBENZENOSULFONAMIDE AND PLATINUM COMPOUNDS |
WO2001087287A2 (en) * | 2000-05-19 | 2001-11-22 | Applied Research Systems Ars Holding N.V. | Use of pyrazole derivatives for treating infertility |
US6822001B2 (en) | 2000-11-03 | 2004-11-23 | Tularik Inc. | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents |
KR100686537B1 (en) * | 2001-12-28 | 2007-02-27 | 씨제이 주식회사 | Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
JP2006503812A (en) * | 2002-07-17 | 2006-02-02 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | Combination of an allosteric carboxyl matrix metalloproteinase-13 inhibitor with a selective cyclooxygenase-2 inhibitor that is not celecoxib or valdecoxib |
KR100484525B1 (en) * | 2002-10-15 | 2005-04-20 | 씨제이 주식회사 | Isothiazole derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same |
AT504159A1 (en) * | 2006-08-16 | 2008-03-15 | Marlyn Nutraceuticals Inc | USE OF PROTEASES |
RU2475257C1 (en) * | 2011-06-22 | 2013-02-20 | Людмила Николаевна Третьяк | Preparation for increasing organism adaptability to extreme conditions |
GB2496135B (en) * | 2011-11-01 | 2015-03-18 | Valirx Plc | Inhibitors of the interaction between a Src family kinase and an androgen receptor or estradiol receptor for treatment of endometriosis |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE9422447U1 (en) * | 1993-01-15 | 2002-10-17 | G D Searle Llc Chicago | 3,4-diarylthiophenes and analogues thereof, and their use as anti-inflammatory agents |
US5436265A (en) * | 1993-11-12 | 1995-07-25 | Merck Frosst Canada, Inc. | 1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents |
DK0923933T3 (en) * | 1993-11-30 | 2002-10-21 | Searle & Co | Substituted pyrazolylbenzenesulfonamides for use in the treatment of inflammation |
US5521213A (en) * | 1994-08-29 | 1996-05-28 | Merck Frosst Canada, Inc. | Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
DE69529690T2 (en) * | 1994-12-21 | 2003-11-13 | Merck Frosst Canada Inc | DIARYL-2 (5H) -FUARANONE AS COX-2 INHIBITORS |
US5691374A (en) * | 1995-05-18 | 1997-11-25 | Merck Frosst Canada Inc. | Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors |
-
1997
- 1997-11-19 UA UA99063447A patent/UA70294C2/en unknown
- 1997-11-19 PL PL97373973A patent/PL194717B1/en unknown
- 1997-11-19 SK SK599-99A patent/SK59999A3/en unknown
- 1997-11-19 AU AU72982/98A patent/AU730211B2/en not_active Ceased
- 1997-11-19 RO RO99-00572A patent/RO118566B1/en unknown
- 1997-11-19 WO PCT/US1997/021489 patent/WO1998022101A2/en not_active Application Discontinuation
- 1997-11-19 ID IDW990379A patent/ID21979A/en unknown
- 1997-11-19 CA CA002270469A patent/CA2270469C/en not_active Expired - Fee Related
- 1997-11-19 EP EP97949579A patent/EP0941080A2/en not_active Withdrawn
- 1997-11-19 IL IL12960497A patent/IL129604A/en not_active IP Right Cessation
- 1997-11-19 CN CN97181368A patent/CN1247470A/en active Pending
- 1997-11-19 JP JP52396098A patent/JP2001505564A/en not_active Withdrawn
- 1997-11-19 RU RU99112952/14A patent/RU2268716C2/en not_active IP Right Cessation
- 1997-11-19 TR TR1999/01703T patent/TR199901703T2/en unknown
- 1997-11-19 BR BR9713522A patent/BR9713522A/en not_active Application Discontinuation
- 1997-11-19 NZ NZ335853A patent/NZ335853A/en not_active Application Discontinuation
- 1997-11-19 CZ CZ991768A patent/CZ176899A3/en unknown
- 1997-11-19 KR KR1019990704392A patent/KR20000053362A/en not_active Application Discontinuation
-
1999
- 1999-04-30 PL PL333370A patent/PL191793B1/en unknown
- 1999-05-12 NO NO992309A patent/NO992309L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20000053362A (en) | 2000-08-25 |
PL191793B1 (en) | 2006-07-31 |
CA2270469C (en) | 2007-04-10 |
EP0941080A2 (en) | 1999-09-15 |
PL194717B1 (en) | 2007-06-29 |
JP2001505564A (en) | 2001-04-24 |
SK59999A3 (en) | 2000-01-18 |
AU730211B2 (en) | 2001-03-01 |
ID21979A (en) | 1999-08-19 |
BR9713522A (en) | 2000-03-21 |
PL333370A1 (en) | 1999-12-06 |
CA2270469A1 (en) | 1998-05-28 |
AU7298298A (en) | 1998-06-10 |
TR199901703T2 (en) | 2000-07-21 |
IL129604A0 (en) | 2000-02-29 |
IL129604A (en) | 2004-08-31 |
CZ176899A3 (en) | 1999-10-13 |
CN1247470A (en) | 2000-03-15 |
WO1998022101A2 (en) | 1998-05-28 |
RU2268716C2 (en) | 2006-01-27 |
WO1998022101A3 (en) | 1998-06-25 |
NO992309L (en) | 1999-05-12 |
RO118566B1 (en) | 2003-07-30 |
UA70294C2 (en) | 2004-10-15 |
NZ335853A (en) | 2002-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0818448T3 (en) | Cycloalkanopyridines as CETP inhibitors | |
NO995077L (en) | Process using cyclooxygenase-2 inhibitors | |
DK1049695T3 (en) | 2-Phenyl-substituted imidazotriazinones as phosphodiesterase inhibitors | |
NO954427D0 (en) | HIV protease inhibitors useful for the treatment of AIDS | |
NO960393D0 (en) | Heterocyclic phenyl compounds as COX-2 inhibitors | |
NO992309D0 (en) | Process for the use of cyclooxygenase-2 inhibitors as anti-angiogenic agents | |
ID23983A (en) | AMINOTIAZOL INHIBITORS FOR CINCINES DEPENDING ON CYCLINES | |
DK0912518T3 (en) | Substituted pyridines as selective cyclooxygenase-2 inhibitors | |
NO20021042L (en) | Benzophenones as inhibitors of reverse transcriptases | |
FI944804A0 (en) | Pyrimidinylacetamide as elastase inhibitors | |
DK1001934T3 (en) | Indole compounds as COX-2 inhibitors | |
FI963597A0 (en) | Isoprenyylitransferaasi inhibitors | |
NO972930D0 (en) | Fibronectin-adhesion inhibitors | |
FI971104A (en) | Process for the preparation of phenyl heterocycles useful as COX inhibitors | |
DK0593294T3 (en) | Amine derivatives as corrosion inhibitors | |
NO20001979L (en) | Use of inhibitors of the renin-angiotensin system | |
DK0975623T3 (en) | Indazolamide compounds as sertoninergic agents | |
NO20001924D0 (en) | Isoquinolines as Urokinase Inhibitors | |
NO922167D0 (en) | AMINODECTS AS CORROSION INHIBITORS | |
DE69523961D1 (en) | Beta-carboline thromboxane synthase inhibitors | |
EE04750B1 (en) | Method for the preparation of HIV protease inhibitors | |
NO983227L (en) | Mixtures consisting essentially of polyethylene, as well as the process for free | |
PT1069885E (en) | GLYCOGENY COMPOSITION OF THE OPHTHALMIC SOLUTION | |
ID26703A (en) | USE OF LOCAL ANESTHESIA FOR VASCULAR HEADACHE | |
NO991400D0 (en) | Procedure for the supply of liquid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |